USP and Public Policy
Left
Refine Your Search
The U.S. Pharmacopeia (USP) recognizes that global coordination, harmonization, and convergence efforts among governments and other stakeholders can facilitate and streamline responses and solutions…
Learn More
101 signatures, including USP, wrote to express the collective strong desire to see the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorized before the end of the calendar year in the same…
Learn More
Identifying and addressing vulnerabilities in the upstream pharmaceutical supply chain are essential to mitigating and preventing drug shortages and to ensuring patients have access to the critical…
Learn More
Addressing Barriers to the Development of Complex Generics: Understanding Challenges and Opportunities
Learn More
Recently, media reports have highlighted the results of drug quality testing from some contract laboratories that are analyzing the quality attributes of human drug products using testing methods…
Learn More
USP Comment Letter to Senators Sanders and Cassidy and Representatives McMorris-Rodgers and Pallone ( ranking members of the Senate HELP Committee and House Energy and Commerce Committee) regarding…
Learn More
Submitted August 18, 2023 to Senators Sanders and Cassidy and Representatives McMorris-Rodgers and Pallone regarding the Request for Information Regarding the Food and Drug Administration Regulation…
Learn More